CVS restores Zepbound coverage, adds Eli Lilly’s obesity pill Foundayo
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on…
Eastern Congo sees a third attack on health centers treating Ebola
KINSHASA, Congo (AP) — Angry young men stormed a hospital treating Ebola patients at the heart of the…
Rare Ebola type spreads in eastern Congo and healthcare workers say they are underprepared
BUNIA, Congo (AP) — Anxious healthcare workers in eastern Congo said Wednesday they are underprotected and undertrained in…
White House adds generic drugs to direct-to-consumer TrumpRx site
President Donald Trump speaks to introduce the TrumpRx website in the South Court Auditorium of the White House…
CDC says there are no U.S. hantavirus cases currently, 41 people being monitored
In this photo illustration Hantavirus samples are seen in Ankara, Turkiye on May 6, 2026. Arman Onal |…
Hantavirus cases spark surge in pharma, biotech stocks — here’s why
ILLUSTRATION of hantavirus testing concept with laboratory tubes containing cotton swabs and HANTAVIRUS labels photographed in front of…
FDA announces first approval of fruit-flavored e-cigarettes for adults
Flavored disposable e-cigarettes are seen in this illustration taken July 18, 2022. Shannon Stapleton | Reuters The Food…
FDA withdrew studies finding Covid, shingles vaccines were safe
The FDA blocked the publication of several studies supporting the safety of vaccines against Covid and shingles in…
Crispr gene editing treatment from Intellia succeeds in Phase 3 trial
Intellia Therapeutics, building exterior and company sign, Cambridge, Massachusetts, USA. Spencer Grant | Universal Images Group | Getty…
Regeneron inks drug pricing deal with Trump, will offer hearing-loss therapy for free
U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office…
Takeaways from RFK Jr.’s gauntlet of congressional hearings
Health Secretary Robert F. Kennedy Jr. on Wednesday concluded a marathon series of hearings with federal lawmakers, during…
Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7B
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company…